Co-Authors
This is a "connection" page, showing publications co-authored by Jason Pitarresi and Nikita Umakant Bhalerao.
Connection Strength
1.297
-
Bhalerao N, Ogoti Y, Peura J, Johnson C, Chen Q, Korobkina ED, Keller FN, Wengyn M, Norgard RJ, Shamber C, Klute K, DiMaio D, Sellin K, Grandgenett PM, Li R, Hollingsworth MA, Guilherme A, Czech MP, Kremer R, Zhu LJ, Spinelli JB, Watson EV, Ruscetti M, Guertin DA, Pitarresi JR. Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose de novo lipogenesis. bioRxiv. 2025 Aug 20.
Score: 0.943
-
Zhou L, DeMarco KD, Murphy KC, Wu Z, Li J, Johnson C, Liu B, Giwa HK, Ma B, Bhalerao N, Li J, Jiang Z, Bai S, Parikh CN, Ye T, Simin K, Zhu LJ, Pitarresi JR, Wu H, Ruscetti M. p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy. Cancer Discov. 2026 Mar 02; 16(3):571-591.
Score: 0.061
-
Abu-Remaileh M, Stransky LA, Bhalerao N, Shirole NH, Jiang Q, Saad E, Machaalani M, Vigeant SM, Woldemichael H, Xu C, Lu J, Wei H, Liu Z, Sun W, Enomoto K, Choueiri TK, Pitarresi JR, Carr SA, Udeshi ND, Kaelin WG. Publisher Correction: argeting of HIF2-driven cachexia in kidney cancer. Nat Med. 2026 Feb; 32(2):766.
Score: 0.061
-
Abu-Remaileh M, Stransky LA, Bhalerao N, Shirole NH, Jiang Q, Saad E, Machaalani M, Vigeant SM, Woldemichael H, Xu C, Lu J, Wei H, Liu Z, Sun W, Enomoto K, Choueiri TK, Pitarresi JR, Carr SA, Udeshi ND, Kaelin WG. Targeting of HIF2-driven cachexia in kidney cancer. Nat Med. 2026 Jan; 32(1):245-257.
Score: 0.060
-
Abu-Remaileh M, Stransky LA, Bhalerao N, Shirole NH, Jiang Q, Saad E, Machaalani M, Vigeant SM, Woldemichael H, Xu C, Lu J, Wei H, Liu Z, Sun W, Enomoto K, Choueiri TK, Pitarresi JR, Carr SA, Udeshi ND, Kaelin WG. HIF2-driven PTHrP Causes Cachexia and Hypercalcemia in Kidney Cancer: Treatment with HIF2 Inhibitors. bioRxiv. 2025 Sep 11.
Score: 0.059
-
Weissenrieder JS, Peura J, Paudel U, Bhalerao N, Weinmann N, Johnson C, Wengyn M, Drager R, Furth EE, Simin K, Ruscetti M, Stanger BZ, Rustgi AK, Pitarresi JR, Foskett JK. Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Rep. 2025 May 27; 44(5):115627.
Score: 0.058
-
Weissenrieder JS, Peura J, Paudel U, Bhalerao N, Weinmann N, Johnson C, Wengyn M, Drager R, Furth EE, Simin K, Ruscetti M, Stanger BZ, Rustgi AK, Pitarresi JR, Foskett JK. Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. bioRxiv. 2024 Aug 09.
Score: 0.055